Case Control Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Aug 28, 2020; 26(32): 4817-4832
Published online Aug 28, 2020. doi: 10.3748/wjg.v26.i32.4817
Table 5 The comparison of human leukocyte antigen alleles which increase or decrease the gastric cancer/duodenal ulcer risk in gastric cancer and duodenal ulcer subgroups in terms of CagA+(≥ 2) EPIYA-C, n (%)
GC(≥ 2) EPIYA-C (n = 26, alleles=52)DU(≥ 2) EPIYA-C (n = 14, alleles=28)OR95%CIP value
MinimumMaximum
HLA-A*0212 (23)10 (36)0.540.191.470.2302
HLA-B*3512 (23)4 (14)1.800.526.210.3527
HLA-DRB1*1312 (23)6 (21)1.100.363.830.8663
HLA-DQA1*0124 (46)10 (36)1.540.593.970.3689
HLA-DRB1*0612 (23)8 (28)0.750.262.120.5889